Therapeutic potential of ketone bodies on exercise intolerance in heart failure: looking beyond the heart
Cardiovascular Research · 22.04.2025 · 121 (2) · 230-240
DOI: 10.1093/cvr/cvaf004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 18.01.2025. Verfasst von Shubham Soni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Centre, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Heart Failure, Exercise Tolerance, Ketone Bodies, Muscle, Skeletal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Canada, Diabetes Canada.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Recent evidence suggests that ketone bodies have therapeutic potential in many cardiovascular diseases including heart failure (HF). Accordingly, this has led to multiple clinical trials that use ketone esters (KEs) to treat HF patients highlighting the importance of this ketone therapy. KEs, specifically ketone monoesters, are synthetic compounds which, when consumed, are de-esterified into two β-hydroxybutyrate (βOHB) molecules and increase the circulating βOHB concentration. While many studies have primarily focused on the cardiac benefits of ketone therapy in HF, ketones can have numerous favourable effects in other organs such as the vasculature and skeletal muscle. Importantly, vascular and skeletal muscle dysfunction are also heavily implicated in the reduced exercise tolerance, the hallmark feature in HF with reduced ejection fraction and preserved ejection fraction, suggesting that some of the benefits observed in HF in response to ketone therapy may involve these non-cardiac pathways. Thus, we review the evidence suggesting how ketone therapy may be beneficial in improving cardiovascular and skeletal muscle function in HF and identify various potential mechanisms that may be important in the beneficial non-cardiac effects of ketones in HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Centre, University of Alberta, Edmonton, Alberta, Canada.
- Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Integrated Cardiovascular and Exercise Physiology and Rehabilitation (iCARE) Lab, Faculty of Nursing, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
- Heart, Exercise and Research Trials Lab, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
ORCID-Profile: Shubham Soni, Stephen Foulkes, Jason R B Dyck
Förderung
- Canadian Institutes of Health Research (CIHR)
- Heart and Stroke Foundation of Canada
- Diabetes Canada
- Canada Research Chair in Molecular Medicine
- CIHR Canada Graduate Doctoral Scholarship
- Izaak Walton Killam Memorial Scholarship
- Alberta Innovates Postdoctoral Fellowship in Health Innovation and Advancement
- Endowed Research Chair in Aging
Zitieren
APA
Soni, S., Skow, R. J., Foulkes, S., Haykowsky, M. J., & Dyck, J. R. B. (2025). Therapeutic potential of ketone bodies on exercise intolerance in heart failure: looking beyond the heart. Cardiovascular Research, 121(2), 230-240. https://doi.org/10.1093/cvr/cvaf004
Vancouver
Soni S, Skow RJ, Foulkes S, Haykowsky MJ, Dyck JRB. Therapeutic potential of ketone bodies on exercise intolerance in heart failure: looking beyond the heart. Cardiovascular Research. 2025;121(2):230-240. doi:10.1093/cvr/cvaf004
BibTeX
@article{Soni2025,
author = {Soni, Shubham and Skow, Rachel J and Foulkes, Stephen and Haykowsky, Mark J and Dyck, Jason R B},
title = {Therapeutic potential of ketone bodies on exercise intolerance in heart failure: looking beyond the heart},
journal = {Cardiovascular Research},
year = {2025},
volume = {121},
number = {2},
pages = {230--240},
doi = {10.1093/cvr/cvaf004}
}
EUVIMED